![Brendan Hannah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brendan Hannah
Compliance Officer chez
QUINCE THERAPEUTICS, INC.
Fortune : 32 906 $ au 30/06/2026
Profil
Brendan Hannah currently works at Quince Therapeutics, Inc. as COO, Chief Business & Compliance Officer since 2023.
Former positions include Director-Business Development at Cidara Therapeutics, Inc., Head-Corporate Development at Agenovir Corp.
from 2017 to 2018, Vice President-Operations & Strategy at Geom Therapeutics, Inc. from 2017 to 2020, Chief Business Officer at Neuroptika, Inc. from 2019 to 2021, and Chief Operating Officer at Novosteo, Inc. from 2021 to 2022.
Education includes an MBA from Anderson School of Management and an undergraduate degree from The Colorado College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 1 809 ( 0,18% ) | 32 906 $ | 30/06/2026 |
Postes actifs de Brendan Hannah
| Sociétés | Poste | Début |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Compliance Officer | 16/03/2023 |
Anciens postes connus de Brendan Hannah
| Sociétés | Poste | Fin |
|---|---|---|
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Directeur des opérations | 01/05/2022 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Corporate Officer/Principal | 01/10/2021 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Corporate Officer/Principal | 01/03/2020 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Corporate Officer/Principal | 01/01/2018 |
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 01/12/2016 |
Formation de Brendan Hannah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
